Long‐term survival of nonlocalized epithelial ovarian cancer among women using menopausal hormone therapy prior to diagnosis: The extreme study

Prediagnostic use of menopausal hormone therapy (MHT) has been suggested to be associated with improved survival of epithelial ovarian cancer (EOC). We investigated the potential long‐term survival benefit of prediagnostic MHT use in women ≥50 years with nonlocalized EOC using the Extreme study incl...

Descripción completa

Detalles Bibliográficos
Autores principales: Baandrup, Louise, Galanakis, Michael, Hannibal, Charlotte G., Dehlendorff, Christian, Hertzum‐Larsen, Rasmus, Mørch, Lina S., Kjaer, Susanne K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Cancer Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541581/
https://www.ncbi.nlm.nih.gov/pubmed/35716136
http://dx.doi.org/10.1002/ijc.34171

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541581/
https://www.ncbi.nlm.nih.gov/pubmed/35716136
http://dx.doi.org/10.1002/ijc.34171

Ejemplares similares